Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Ashok Badithe"'
Autor:
Selin Somersan-Karakaya, Kenneth C. Turner, Luz Cortes-Burgos, Jutta Miller, Michael LaCroix-Fralish, Veronika Logovinsky, Yamini Patel, Richard Torres, Samit Ganguly, Aurora Breazna, Michelle DeVeaux, Rafia Bhore, Min Gao, Frank J. Delfino, Ashique Rafique, Jeanette L. Fairhurst, Charleen Hunt, Robert Babb, Ashok Badithe, William T. Poueymirou, Ronald Surowitz, Sylvie Rottey, Andrew J. Murphy, Olivier Harari, Lynn E. Macdonald, Susan D. Croll
Publikováno v:
Neurobiology of Pain, Vol 14, Iss , Pp 100136- (2023)
The artemin-GFRα3 signaling pathway has been implicated in various painful conditions including migraine, cold allodynia, hyperalgesia, inflammatory bone pain, and mouse knees contain GFRα3-immunoreactive nerve endings. We developed high affinity m
Externí odkaz:
https://doaj.org/article/c0682c375e514d369668aca491d09e17
Autor:
Shanmugam, Arulkumaran, Suriano, Robert, Goswami, Neha, Chaudhuri, Devyani, Ashok, Badithe T., Rajoria, Shilpi, George, Andrea L., Mittelman, Abraham, Tiwari, Raj K.
Publikováno v:
Cell Stress & Chaperones, 2011 Mar 01. 16(2), 225-234.
Externí odkaz:
https://www.jstor.org/stable/41331363
Autor:
Candice Boutot, Olav Olsen, Vishal Kamat, Jing Wang, Ashok Badithe, Ashique Rafique, Christian Granados, Marcela Torres, William C. Olson, Tammy T. Huang, Ishita Chatterjee
Publikováno v:
Analytical biochemistry. 640
We recently demonstrated that capturing human monoclonal antibodies (hmAbs) using high affinity anti-human Fc (AHC) antibodies allows reliable characterization of antibody-antigen interactions. Here, we characterized six human Fc specific mouse monoc
Autor:
William C. Olson, Matthew C. Franklin, Li-Hong Ben, George D. Yancopoulos, Jamie M. Orengo, Annabel Romero Hernandez, Vishal Kamat, Matthew A. Sleeman, Ashok Badithe, Joannie Bautista, Jennifer Jones, Andrew J. Murphy, Amanda Atanasio
Publikováno v:
The Journal of allergy and clinical immunology. 149(1)
Background Blocking the major cat allergen, Fel d 1, with mAbs was effective in preventing an acute cat allergic response. Objectives This study sought to extend the allergen-specific antibody approach and demonstrate that a combination of mAbs targe
Autor:
Pamela Krueger, James Shevchuk, Joannie Bautista, Macdonald Lynn, Natasha Levenkova, Saurabh Wadhwa, Cagan Gurer, Johanna Hansen, Douglas MacDonald, Tammy T. Huang, Ashique Rafique, Kenneth S. Graham, Lakeisha Esau, Matthew C. Franklin, George Ehrlich, Ashok Badithe, George D. Yancopoulos, Maggie Zhong, Andrew J. Murphy, Chunguang Guo, Vera Voronina, Robert Babb, Gang Chen, Naxin Tu, Morton Lori C, Craig Grant, William Poueymirou, Karoline A Meagher, Wojtek Auerbach, John Mcwhirter
Publikováno v:
Proc Natl Acad Sci U S A
We describe a Kappa-on-Heavy (KoH) mouse that produces a class of highly diverse, fully human, antibody-like agents. This mouse was made by replacing the germline variable sequences of both the Ig heavy-chain (IgH) and Ig kappa (IgK) loci with the hu
Publikováno v:
Analytical Chemistry. 90:11315-11323
Epitopes of a native pollen allergen protein, birch Bet v1, against four of the noncompeting anti-Bet v1 antibodies individually or in combination, were identified by solution-phase amide backbone H/D exchange (HDX) coupled with high-resolution Q-TOF
Autor:
Andrew B. Ward, Christos A. Kyratsous, Ricardo Carrion, Gabriella Worwa, William D. Pratt, Gang Chen, William C. Olson, Terra Potocky, Joel H. Martin, Karl J. Erlandson, John C. Trefry, Ashique Rafique, Peter W. Mason, Hilary M. Staples, Tammy T. Huang, Hannah L. Turner, Robert Babb, Drew Dudgeon, Leah Lipsich, Joshua D. Shamblin, Ying Yan, Yasuteru Sakurai, Thomas M Dreier, Manu Anantpadma, Kevin Yu, Marcela Torres, Sandra L. Bixler, Suzanne E. Wollen, Charles D. Murin, Neil Stahl, Justine M. Zelko, Melissa S Willis, Robert A. Davey, Darya Burakov, Jeanette L. Fairhurst, Ashok Badithe, Margaret L. Pitt, Franco Rossi, Taylor B. Chance, Kimberly Armstrong, Kristen E. Pascal
Publikováno v:
The Journal of Infectious Diseases
Background For most classes of drugs, rapid development of therapeutics to treat emerging infections is challenged by the timelines needed to identify compounds with the desired efficacy, safety, and pharmacokinetic profiles. Fully human monoclonal a
Autor:
Ashok, Badithe T. ∗, Ali, Rashid
Publikováno v:
In Experimental Gerontology 2003 38(6):597-603
Autor:
Amanda Atanasio, Jamie M. Orengo, Matthew A. Sleeman, Li-Hong Ben, Joannie Bautista, Vishal Kamat, Andrew J. Murphy, Ashok Badithe, Annabel Romero Hernandez, Matthew C. Franklin, William C. Olson
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:AB62
Autor:
Ka Man V. Lai, Christopher M. Coleman, Kristen E. Pascal, Alejandro O. Mujica, Christos A. Kyratsous, Robert Babb, Vishal Kamat, Matthew B. Frieman, Ashok Badithe, Krystal Matthews, Neil Stahl, Charleen Hunt, Alexander Berrebi, Tammy T. Huang, Jeanne M. Sisk, Gang Chen, Jeanette L. Fairhurst, George D. Yancopoulos, William C. Olson, John Strein
Publikováno v:
Proceedings of the National Academy of Sciences
Traditional approaches to antimicrobial drug development are poorly suited to combatting the emergence of novel pathogens. Additionally, the lack of small animal models for these infections hinders the in vivo testing of potential therapeutics. Here